Tradestie Institutional Equity Comparison Engine

PYPD vs OVID โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PYPD Overall Edge

PYPD Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to PolyPid Ltd. Ordinary Shares (PYPD) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while OVID counters with relative strength in Valuation. Fundamentally, PYPD trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus OVID at 1.8x Forward P/E and -4693.7% operating margin (-88.3% YoY). In options structure, PYPD sits in BREAKOUT (12th %ile IV; Dealer Gamma Walls on Pro) against OVID sits in CONSOLIDATION (30th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner OVID
PYPD N/M vs OVID 1.8x Fwd P/E
Growth & Margin Winner PYPD
Op Margin 0.0% vs -4693.7% ยท YoY +0.0% vs -88.3%
Momentum & Technical Winner PYPD
1Y +79.2% vs +73.6% ยท 52W Pos 80% vs 56%
Options & Structure Winner PYPD
BREAKOUT (12th %ile IV) vs CONSOLIDATION (30th %ile IV)
PYPD NASDAQ
PolyPid Ltd. Ordinary Shares
Surgical & Medical Instruments & Apparatus
$6.43
+4.63% 1D
Market Cap $132.2M
1M Return +31.86%
1Y Return +79.25%
Forward P/E N/M
Unified AI Score
31.1 / 100 SELL
Tech 50.0 Fund 27.0 Flow 56.0 Mom 32.0
OVID NASDAQ
Ovid Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$2.27
-5.62% 1D
Market Cap $479.4M
1M Return +4.38%
1Y Return +73.56%
Forward P/E 1.8x
Unified AI Score
52.3 / 100 HOLD
Tech 29.0 Fund 48.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PYPD +79.25% OVID +73.56% Spread: +5.69 pp (PYPD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
PYPD TTM Op. Margin: 0.0% OVID TTM Op. Margin: -4693.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PYPD vs OVID. Trailing 12-month operating profitability (PYPD 0.0% vs OVID -4693.7%) and valuation multiples (PYPD N/M vs OVID 1.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PYPD (4) vs OVID (5)
Institutional Metric PYPD OVID Criterion Row Winner
Market Capitalization Scale $132.2M $479.4M Larger Scale OVID
Trailing P/E Ratio Valuation N/M 1.8x Lower Multiple OVID
Forward P/E Ratio Valuation N/M 1.8x Lower Multiple OVID
Revenue Growth (YoY) Growth +0.0% -88.3% Higher Growth PYPD
Operating Margin (TTM) Profitability 0.0% -4693.7% Higher Margin PYPD
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -243.6% -35.4% Higher ROE OVID
52-Week Range Position Momentum 80% ($4โ€“$7) 56% ($1โ€“$3) Stronger Trend PYPD
Beta / 30D Volatility Risk Regime 0.89ฮฒ ยท 59% Vol 1.04ฮฒ ยท 99% Vol Lower Realized Risk PYPD
Unified Institutional Score Composite Signal 31.1 / 100 (SELL) 52.3 / 100 (HOLD) Higher Composite OVID

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PYPD vs OVID Buy Guide
PYPD BREAKOUT
40d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 12th %ile
IV Regime Compressed (<25th %ile)
Live PYPD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OVID CONSOLIDATION
151d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 30th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live OVID Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PYPD nor OVID registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.